CINECA IRIS Institutional Research Information System

EGIDI, MARIA FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.484
EU - Europa 2.049
AS - Asia 1.613
AF - Africa 139
SA - Sud America 32
OC - Oceania 7
Totale 11.324
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.307
CN - Cina 868
SE - Svezia 793
IT - Italia 418
BG - Bulgaria 307
SG - Singapore 295
DE - Germania 176
CA - Canada 173
HK - Hong Kong 126
VN - Vietnam 126
RU - Federazione Russa 120
SN - Senegal 105
TR - Turchia 92
GB - Regno Unito 54
UA - Ucraina 52
KR - Corea 47
AT - Austria 45
CI - Costa d'Avorio 30
BR - Brasile 24
BE - Belgio 18
FI - Finlandia 17
IN - India 16
DK - Danimarca 13
TW - Taiwan 13
JP - Giappone 12
AU - Australia 5
FR - Francia 5
SK - Slovacchia (Repubblica Slovacca) 4
UZ - Uzbekistan 4
CZ - Repubblica Ceca 3
ES - Italia 3
LT - Lituania 3
PE - Perù 3
PT - Portogallo 3
RO - Romania 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
MY - Malesia 2
NG - Nigeria 2
NL - Olanda 2
NZ - Nuova Zelanda 2
PL - Polonia 2
TH - Thailandia 2
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
GD - Grenada 1
GL - Groenlandia 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MX - Messico 1
PK - Pakistan 1
SA - Arabia Saudita 1
SC - Seychelles 1
Totale 11.324
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.200
Fairfield 951
Houston 703
Santa Clara 551
Seattle 442
Ashburn 423
Ann Arbor 406
Chandler 391
Wilmington 345
Cambridge 307
Sofia 307
Shanghai 270
Beijing 211
New York 177
Ottawa 161
Des Moines 152
Boardman 134
Princeton 132
Lawrence 130
Medford 126
Hong Kong 125
Dakar 105
Singapore 102
Nanjing 95
Milan 68
Dearborn 63
Istanbul 58
San Diego 57
Dong Ket 44
Grafing 41
Vienna 39
Abidjan 30
Kunming 27
Pisa 25
Frankfurt am Main 23
Serra 23
Nanchang 21
Florence 20
Izmir 20
Falls Church 19
Hefei 18
Brussels 17
Guangzhou 16
Hebei 16
Quanzhou 15
Changsha 14
Jiaxing 14
Copenhagen 13
Kocaeli 13
London 13
Shenyang 12
Fuzhou 11
Jacksonville 8
Bremen 7
Los Angeles 7
Norwalk 7
Phoenix 7
Toronto 7
Chengdu 6
Lancaster 6
Lucca 6
Nuremberg 6
Rome 6
Cascina 5
Chongqing 5
Council Bluffs 5
Dallas 5
Genova 5
Hangzhou 5
Helsinki 5
Jinan 5
Mountain View 5
Ogden 5
Redwood City 5
Regensburg 5
San Jose 5
Washington 5
Wuhan 5
Xiamen 5
Blacktown 4
Bratislava 4
Capannori 4
Costa Mesa 4
Ningbo 4
Tianjin 4
Zhengzhou 4
Castellammare Di Stabia 3
Chicago 3
Genoa 3
Indiana 3
Kaohsiung 3
Kilburn 3
Livorno 3
Montevideo 3
Munich 3
Piemonte 3
Pontedera 3
Renton 3
Rochester 3
San Francisco 3
Totale 8.919
Salva come PNG Salva come JPEG
Nome #
Approccio incrementale di inizio dialisi: emodialisi bisettimanale, o monosettimanale associata a dieta ipoproteica-ipofosforica? [Incremental approach to hemodialysis: twice a week, or once weekly hemodialysis combined with low-protein low-phosphorus diet?] 226
Nephrolithiasis and hypertension: possible links and clinical implications. 184
The extra-phosphate intestinal load from medications: is it a real concern? 151
Outcomes of African-American kidney-transplant recipients treated with sirolimus, tacrolimus, and corticosteroids 149
Long-Term (5 Years) Efficacy and Safety of Pancreas Transplantation Alone in Type 1 Diabetic Patients 148
Nutritional support in the tertiary care of patients affected by chronic renal insufficiency: Report of a step-wise, personalized, pragmatic approach 146
Transplantation of the pancreas 138
Nutrition and physical activity in CKD patients. 128
Blood pressure phenotype reproducibility in CKD outpatients: a clinical practice report 122
Improving results in solitary pancreas transplantation with portal-enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil-based immunosuppression 121
Ciclosporin in cadaveric renal transplants 120
"Dietaly": practical issues for the nutritional management of CKD patients in Italy. 120
A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes 119
Renal allograft loss as the result of polyomavirus interstitial nephritis after simultaneous kidney-pancreas transplantation: results with kidney retransplantation 118
Fine-needle aspiration biopsy in renal transplantation: a review of cytologic features 117
Prolactin, thymulin and zinc in chronic hemodialysis: effect of renal transplant 117
Prevention and management of hyperglycemia after pancreas transplantation 116
Long-term experience with simultaneous kidney-pancreas transplantation with portal-enteric drainage and tacrolimus/mycophenolate mofetil-based immunosuppression 114
Autoimmune hemolytic anemia in a cadaveric renal transplant recipient treated with cyclosporine 113
A 9-year experience with 126 pancreas transplants with portal enteric drainage 112
Vitamin D status and cholecalciferol supplementation in chronic kidney disease patients: An Italian cohort report 112
Ciclosporin alone or associated with steroid for immunosuppression of cadaveric renal transplants? 111
Comparison of azathioprine and mycophenolate mofetil in pancreas transplantation 110
Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy 108
Potential Differences in Kidney Allograft Outcomes Between Ethnicities When Converting to Sirolimus Base Immunosuppression 107
Allograft pancreatectomy after pancreas transplantation with systemic-bladder versus portal-enteric drainage 106
Surgical complications after pancreas transplantation with portal-enteric drainage 105
Cyclosporine in cadaveric renal transplantation 104
Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients 104
Risk factors for relapse and long-term outcome of idiopathic retroperitoneal fibrosis 104
Spontaneous arterioenteric fistula after pancreas transplantation 103
Combined simultaneous kidney/bone marrow transplantation 101
Three years of follow-up of bone marrow-augmented organ transplant recipients: the impact on donor-specific immune modulation 101
Are autoimmune diseases or glomerulonephritis affecting the development of panel-reactive antibodies in candidates for renal transplantation? 100
Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: A 44 month follow-up 100
Clinical utility of histological features of polyomavirus allograft nephropathy 100
Surveillance and monitoring of pancreas allografts 99
Controlled trial of two different methylprednisolone doses in cadaveric renal transplantation 99
Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation 99
Evolution in pancreas transplantation techniques: simultaneous kidney-pancreas transplantation using portal-enteric drainage without antilymphocyte induction 98
Enteric-drained pancreas transplants monitored by fine-needle aspiration biopsy 98
Conversion to sirolimus in solid organ transplantation: a single-center experience 97
Serum lipase as a marker for pancreatic allograft rejection 97
Posttransplant lymphoproliferative disorders: single center experience 97
Experience with Portal-Enteric Pancreas Transplantation at the University of Tennessee-Memphis 96
Surgical complications in 123 consecutive pancreas transplant recipients: comparison of bladder and enteric drainage 96
Pancreas transplantation with enteric drainage under tacrolimus induction therapy 96
An ideal nondiabetogenic, nonnephrotoxic immunosuppressive protocols for pancreas transplantation 95
Morphologic patterns of renal allograft rejection 95
Long-term results of pancreas transplantation under tacrolimus immunosuppression 94
Role of surveillance biopsies in monitoring recipients of pancreas alone transplants 94
Comparison of efficacy of induction therapy in low immunologic risk African-American kidney transplant recipients 93
Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience 93
Long-term outcomes in simultaneous kidney-pancreas transplant recipients with portal-enteric versus systemic-bladder drainage 92
En bloc pancreas and kidney transplantation in a patient with limited vascular access 91
A prospective comparison of simultaneous kidney-pancreas transplantation with systemic-enteric versus portal-enteric drainage 91
Can preemptive cytomegalovirus monitoring be as effective as universal prophylaxis when implemented as the standard of care in patients at moderate risk? 91
Fine Needle Aspiration Biopsy in Kidney and Pancreas Transplantation 91
Approaches to Minimize Delayed Graft Function in Renal Transplantation 91
null 89
Pancreas Transplantation 89
Pancreas transplantation without antibody therapy 89
The importance of early prevention of renal dysfunction in liver transplant recipients 89
Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus era 88
Outcomes of simultaneous kidney-pancreas transplantation in African-American recipients: a case-control study 88
Posttransplant quality of life: a decade of descriptive studies leading to practice interventions 88
Serum lipase as a marker for pancreatic allograft rejection 87
Long-term outcomes in simultaneous kidney-pancreas transplant recipients with portal-enteric versus systemic-bladder drainage 87
Human granulocytic ehrlichiosis in pancreas transplant recipients 86
Polyomavirus in kidney and kidney-pancreas transplant recipients 86
Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients 86
Observations regarding the use of sirolimus and tacrolimus in high-risk cadaveric renal transplantation 85
Experience with Portal-Enteric Pancreas Transplantation at the University of Tennessee Memphis 85
A prospective comparison of systemic-bladder versus portal-enteric drainage in vascularized pancreas transplantation 84
Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation 84
Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone 84
Impact of hepatitis C virus status in pancreas transplantation: a case controlled study 83
Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis 83
Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation 82
Efficacy of induction therapy on acute rejection and graft outcomes in African American kidney transplantation 82
Outcome of simultaneous kidney-pancreas transplantation in African-American recipients: a case control study 81
Lifestyle behaviors affect cardiovascular risk status in men 1 year after kidney transplantation 80
Simultaneous kidney-pancreas transplantation without antilymphocyte induction 80
Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction 80
Renal fine-needle biopsy 80
Improving results in solitary pancreas transplantation with portal-enteric drainage and thymoglobulin induction 79
Experience with portal-enteric pancreas transplantation at the University of Tennessee, Memphis 79
Renal Involvement in IgG4-Related Disease: From Sunlight to Twilight 79
Rhodococcus equi pulmonary infection in a pancreas-alone transplant recipient: consequence of intense immunosuppression 78
Simultaneous kidney-pancreas transplant with systemic-enteric versus portal-enteric drainage 78
A search for optimizing corticosteroid administration to renal transplant patients 78
Evolving experience of hepatitis B virus prophylaxis in liver transplantation 77
Medical Management After Pancreas Transplantation 77
Nine-year experience with 126 pancreas transplants with portal-enteric drainage 77
Management of the nephrotoxicity of cyclosporine in cadaveric renal transplant recipients 75
Long-term follow-up of IgA mesangial nephropathy: clinico-histological study in 374 patients 75
Renal pathology and clinical presentations of polyomavirus nephropathy in simultaneous kidney pancreas transplant recipients compared with kidney transplant recipients 74
A controlled prospective trial of triple therapy with low-dose azathioprine, cyclosporine, and methylprednisolone in renal transplantation 74
The superiority of tacrolimus in renal transplant recipients - the Pittsburgh experience 73
Inflammatory biomarkers, glycemic variability, hypoglycemia, and renal transplant outcomes: Results of a randomized controlled trial 70
Totale 9.886
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.033
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.033
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020548 0 0 0 0 0 0 0 0 203 127 166 52
2020/2021748 69 58 45 40 43 37 26 45 103 81 52 149
2021/20221.503 41 100 27 122 274 199 32 92 69 33 114 400
2022/20231.619 244 213 130 104 132 280 24 135 277 7 66 7
2023/2024706 53 67 77 28 91 165 34 35 5 6 27 118
2024/20251.580 7 137 9 180 351 405 258 137 96 0 0 0
Totale 11.626